CervoMed to Present at the Emerging Growth Conference
Rhea-AI Summary
CervoMed (NASDAQ: CRVO) announced that Matthew Winton, Ph.D., Chief Commercial and Business Officer, will present a corporate presentation at the Emerging Growth Conference on Wednesday, October 22, 2025. The virtual presentation is scheduled for 11:25–11:55 AM ET. A live webcast and replay will be available via the provided webcast link and in the Investor section of the CervoMed website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CRVO gained 6.07%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
BOSTON, Oct. 20, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Matthew Winton, Ph.D., Chief Commercial and Business Officer, will present at the Emerging Growth Conference, being held virtually on Wednesday, October 22, 2025.
Presentation Details
Format: Corporate Presentation
Date: Wednesday, October 22, 2025
Time: 11:25 – 11:55 AM ET
Webcast Link: https://goto.webcasts.com/starthere.jsp?ei=1717092&tp_key=1ddfafa563&sti=crvo
The webcast and replay of the presentation will be accessible in the Investor section of the CervoMed website https://www.cervomed.com/.
About CervoMed
CervoMed is a clinical-stage company focused on developing treatments for age-related neurologic disorders. The Company is currently developing neflamapimod, an investigational, orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in DLB and certain other major neurological disorders. The Company’s recently completed Phase 2b trial evaluated neflamapimod in patients with DLB.
Investor Contact:
PJ Kelleher
LifeSci Advisors
Investors@cervomed.com
617-430-7579
FAQ
When will CervoMed (CRVO) present at the Emerging Growth Conference?
Who is presenting for CervoMed (CRVO) at the October 22, 2025 conference?
How can investors watch the CervoMed (CRVO) Emerging Growth Conference presentation?
What is the duration of CervoMed's (CRVO) October 22, 2025 presentation?
Where will the CervoMed (CRVO) webcast replay be posted after the event?
